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Previews
the SCA7 patients often present with a retinal degenera-Qs in the Nucleus
tion. La Spada et al. report on the development and
characterization of a SCA7 transgenic mouse model that
seems to replicate nicely the retinal aspects of this dis-
ease. Using several molecular approaches, they go on
The polyglutamine diseases include at least nine neu- to demonstrate that the SCA7-encoded protein ataxin-7
rodegenerative disorders. Accumulation of mutant pro- interacts with a cone-rod homeobox protein, CRX. CRX
tein with a toxic gain-in function in the nucleus appears is critical for the proper expression of several photore-
to be the pathological basis of these diseases. In this ceptor-specific genes (Chen et al., 1997). Of interest is
issue of Neuron, La Spada et al. (2001) provide insight the particular importance of CRX for gene expression in
into the cell specificity of pathology for a polyglutamine cones. Mutations in CRX cause cone-rod degeneration
disease by relating SCA7-induced retinal degeneration similar to that seen in the SCA7 mice.
to a disruption of the photoreceptor-specific transcrip- From these data, La Spada et al. (2001) hypothesize
tion factor CRX. that ataxin-7 induces an alteration of CRX function. To gain
support for this hypothesis, they use real-time RT-PCR to
show that in the retinas of the SCA7 mice expressionTen years ago, almost to the month, Al LaSpada, Kurt
of the CRX-responsive genes encoding blue cone opsinFischbeck, and colleagues (1991) revealed a novel muta-
(BCP), cone arrestin (CARR), rod--transducin (GNAT1),tional mechanism in humans, when they reported that
and rhodopsin (RHO) is depressed. Importantly, this al-X-linked spinal and bulbar muscular atrophy (SBMA or
tered gene expression is detected early in disease pro-Kennedy’s disease) is caused by the growth of a polyglu-
gression in the SCA7 mice, suggesting that it reflectstamine (polyQ) tract in the androgen receptor (AR). In
an initial step in pathogenesis. Of note, the alteration inthe ensuing decade, eight other neurodegenerative dis-
expression of these genes appears to be CRX specific,orders, including Huntington disease and several domi-
since expression of a photoreceptor-specific gene notnantly inherited ataxias, have been shown to be caused
regulated by CRX, encoding rhodopsin kinase (RHOK),by the expansion of a polyQ stretch. While many insights
was not affected in the SCA7 mice. Furthermore, theinto the molecular basis of these disorders have been
reduction of the cone-specific genes BCP and CARR ismade, two fundamental and perplexing questions re-
greater than the reduction in expression of the rod-main unresolved. (1) Does neurotoxicity in the polyQ
specific genes RHO and GNAT1. Thus, a mutant ataxin-diseases occurr by a common pathogenic process? (2)
7-induced dysfunction in CRX is likely the molecularWhat is the molecular basis for the cell-specific pattern
basis for the cone-rod dystrophy seen in the SCA7 miceof pathology that is an important part of the clinical
and perhaps in SCA7 patients.
definition of each disease?
The results of the La Spada et al. (2001) paper are
For an increasing number of the polyQ disorders,
noteworthy in that they provide strong insight into how
evidence is accumulating that an alteration(s) in nuclear a mutant polyQ protein might induce a cell-specific dys-
function underlies pathology. Most of the proteins with function and subsequent degeneration. This example is
a disease causing polyQ expansion are novel proteins particularly compelling. It is consistent with the growing
whose functions remain unknown. However, in two of body of data indicating that an alteration in gene expres-
the three instances where the polyQ elongation affects sion, by a process within the nucleus, underlies polyQ
a known protein, the protein functions in the nucleus: disease. Returning to the two unresolved crucial ques-
SBMA and the AR; and SCA17 and the TATA binding tions facing the polyQ disease field raised above: (1)
protein (Koichiro et al., 2001). In the case of SCA1, the Does the neurotoxicity in the polyQ diseases occurr by a
mutant protein must enter the nucleus for neurotoxicity common pathogenic process? (2) What is the molecular
to develop in a transgenic mouse model (Klement et al., basis for the cell-specific pattern of pathology in each
1998) and cause specific alterations in gene expression disorder? The results reported by La Spada et al. (2001)
(Lin et al., 2000). An increasing number of key compo- suggest that researchers working on other polyQ disor-
nents of the transcription apparatus localize to the nu- ders might do well to seek out a cell-type-specific tran-
clear accumulations of the mutant polyQ protein that scription factor that interacts with their respective polyQ
are a pathological hallmark of these disorders. Among protein. A pathogenic mechanism that involves the dis-
these are the CREB binding protein CBP (McCampbell ruption of transcription in a relatively neuron-type-specific
et al., 2000; Nucifora et al., 2001) and the nuclear core- fashion would be a common mechanism that manifests
pressor N-COR (Boutell et al., 1999). While these studies with cell-specific pathology.
provide considerable support for the nucleus being the
subcellular site important in polyQ pathogenesis, they
provide little insight into the cell specificity of pathology.
In this issue of Neuron, La Spada and colleagues Harry T. Orr
(2001) provide insight into how cell-type specificity Institute of Human Genetics
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Selected Reading cess the two proteins physically associate into clusters
that lead to spine formation (see Figure).
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that is transduced by B-type ephrins (Cowan and Henke-
meyer, 2001), the phosphorylation of syndecan cyto-
plasmic tyrosine residues may also lead to intracellular
signal transduction. Indeed, Ethell and Yamaguchi
(1999) found that spine maturation requires a region ofEph Receptors Tingle the Spine
the syndecan-2 cytoplasmic domain that encompasses
two of the four conserved tyrosines. Thus, syndecan-2
is localized to dendritic spines and its phosphorylation
is implicated in spine maturation.During the development of excitatory synapses, mole-
With this information, Ethell et al. (2001) asked:cules cluster on dendrites to form postsynaptic densi-
what is the physiologically relevant kinase that phos-ties, and specialized structures known as spines ap-
phorylates syndecan-2 in the developing dendriticpear. EphB2 is demonstrated to control this process
spine? And, furthermore, how does syndecan-2 becomeby associating with and phosphorylating a key post-
localized to the spines? In the peripheral nervous sys-synaptic molecule, syndecan-2, thereby initiating the
tem, clustering of molecules at the postsynaptic mem-maturation of dendritic spines.
brane is initiated by activation of the receptor tyrosine
kinase MuSK (Sanes and Lichtman, 1999). The presence
Neural transmission occurs at synapses, which are of several EphB receptors at postsynaptic specializa-
highly specialized cell-cell contacts that form between tions in the hippocampus (Torres et al., 1998; Buchert
presynaptic neurons and their postsynaptic targets. et al., 1999) suggested that these receptors may play a
Molecules involved in receiving and transducing neuro- similar role in the central nervous system. Moreover,
transmitter signals cluster at distinct regions of the mem- EphB receptors can bind several synaptic PDZ-domain
brane to form the postsynaptic specialization. While much proteins as well as, in a ligand-dependent manner,
progress has been made in recent years concerning NMDA receptors (Hock et al., 1998; Torres et al., 1998;
the morphogenesis of postsynaptic specializations in the Buchert et al., 1999; Dalva et al., 2000). In addition,
peripheral nervous system at the neuromuscular junction B-type ephrins stimulate the formation of excitatory syn-
(Sanes and Lichtman, 1999), the identity of signals that apses in cultured neurons (Dalva et al., 2000).
regulate the development of postsynaptic specializations The authors tested the theory that EphB receptors
in the central nervous system has remained elusive. may influence synapse development by interacting with
Most postsynaptic specializations for excitatory syndecan-2. They found that EphB2 and syndecan-2
synapses in the central nervous system are localized to colocalize in neurons and that they physically associate
dendritic spines, which are mushroom-like protrusions both in transfected cells and in the developing brain. It
that decorate the dendrites of the receiving cell. These is unclear whether the interaction between EphB2 and
spines develop after neuronal connectivity has been syndecan-2 is direct or whether there may be intermedi-
established, and changes in their morphology have been ate adaptor proteins that bridge the two molecules. Both
associated with synaptic plasticity and long-term mem- EphB2 and syndecan-2 bind synaptic PDZ-domain pro-
ory (Yuste and Bonhoeffer, 2001). A report in this issue teins, which are likely to participate in clustering of mole-
of Neuron by Ethell et al. (2001) provides evidence that cules at the synapse. However, the PDZ binding domain
spine morphogenesis is controlled by the receptor tyro- of syndecan-2 is not required for the interaction with
sine kinase EphB2. The idea is that EphB2 phosphory- EphB2, suggesting that the PDZ-domain proteins may
recruit additional proteins after the EphB2/syndecan-2lates the cytoplasmic tail of syndecan-2 and in the pro-
